Artivion Inc
NYSE: AORT · HEALTHCARE · MEDICAL DEVICES
Updated 2026-06-05
Artivion Inc (AORT) Financial statements
SEC filings — annual and quarterly data.
Margin trends — annual
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $81.31M | $365000.00 | 53.98% | -1.48% | 0.45% |
| 2007 | $94.76M | $7.20M | 62.49% | 8.76% | 7.60% |
| 2008 | $105.06M | $32.91M | 64.53% | 13.00% | 31.32% |
| 2009 | $111.69M | $8.68M | 62.47% | 12.98% | 7.77% |
| 2010 | $116.64M | $3.94M | 58.61% | 8.46% | 3.38% |
| 2011 | $119.63M | $7.37M | 63.40% | 9.73% | 6.16% |
| 2012 | $131.72M | $7.95M | 64.55% | 9.58% | 6.03% |
| 2013 | $140.76M | $16.17M | 64.21% | 9.82% | 11.49% |
| 2014 | $144.64M | $7.32M | 63.12% | 6.11% | 5.06% |
| 2015 | $145.90M | $4.00M | 62.18% | 3.67% | 2.75% |
| 2016 | $180.38M | $10.78M | 65.92% | 12.10% | 5.98% |
| 2017 | $189.70M | $3.70M | 67.81% | 4.20% | 1.95% |
| 2018 | $262.84M | $-3.81M | 65.81% | 3.54% | -1.45% |
| 2019 | $276.22M | $1.72M | 66.26% | 6.17% | 0.62% |
| 2020 | $253.23M | $-16.68M | 66.26% | 0.96% | -6.59% |
| 2021 | $298.84M | $-14.83M | 66.09% | 2.72% | -4.96% |
| 2022 | $313.79M | $-19.19M | 64.54% | 1.98% | -6.12% |
| 2023 | $354.00M | $-30.69M | 64.74% | 1.62% | -8.67% |
| 2024 | $388.54M | $-13.36M | 64.03% | 10.01% | -3.44% |
| 2025 | $441.33M | $9.77M | 61.28% | 6.06% | 2.21% |
Frequently asked questions
What is Artivion Inc's revenue?
Artivion Inc's trailing twelve-month revenue is $458.69M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How profitable is AORT?
In its most recent fiscal year, AORT ran a gross margin of 61.28%, an operating margin of 6.06%, and a net margin of 2.21%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.
How much free cash flow does AORT generate?
AORT produced $-911000.00 in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is AORT's balance sheet healthy?
AORT holds $64.91M in cash and equivalents against $215.11M in long-term debt, on $448.23M of shareholder equity. That debt is best read against the cash flow the business throws off each year.